Vlad Vitoc - 10 Feb 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Vlad Vitoc
Issuer symbol
MAIA
Transactions as of
10 Feb 2025
Transactions value $
$0
Form type
4
Filing time
12 Feb 2025, 16:10:50 UTC
Previous filing
07 Nov 2024
Next filing
16 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +400K $0.00 400K 10 Feb 2025 Common Stock 400K $1.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on February 10, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.